Exclusion of ZFM1 as a candidate gene for multiple endocrine neoplasia type 1 (MEN1)

Human Genetics

Volumn 99, Issue 5, 1997, Pages 585-589

  Lloyd, S E ^a   Pang, J T ^a   Pearce, S H S ^a   Leigh, S E A ^a   Thakker, R V ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROLINE;

ARTICLE; CHROMOSOME 11Q; DNA FLANKING REGION; DNA SEQUENCE; EXON; GENE DELETION; GENE MAPPING; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE ENDOCRINE NEOPLASIA; MUTATION; NORTHERN BLOTTING; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARRIER PROTEINS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; DNA; DNA PRIMERS; DNA-BINDING PROTEINS; EXONS; GENE DELETION; GENETIC MARKERS; HUMANS; INTRONS; LEUKOCYTES; LINKAGE (GENETICS); MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0030983729     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050410     Document Type: Article

References (23)

1. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237 : 268-275
2. Bystrom C, Larsson C, Blomberg C, Sandelin K, Falkmer U, Skogseid B, Oberg K, et al (1990) Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 87 : 1968-1972
3. De Wit MJ, Landsvater RM, Sinke RJ, vanKessel AG, Lips CJM, Höppener JWM (1996) Exclusion of the phosphatidylinositol-specific phospholipase Cβ3 (PLCβ3) gene as a candidate for the multiple endocrine neoplasia type I (MENI) gene. Hum Genet (in press)
4. Friedman E, Sakaguchi K, Bale AE, Falchetti A, Streeten E, Zimering MB, Weinstein LS, et al (1989) Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 321 : 213-218
5. Grimmond S, Weber G, Larsson C, Walters M, Teh B, Shepherd J, Nordenskjold M, Hay ward N (1995) Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate gene for multiple endocrine neoplasia type 1. Hum Genet 95 : 455-458
6. Kas K, Weber G, Merregaert J, Michiels L, Sandelin K, Skogseid B, Thompson N, et al (1993) Exclusion of FAU as the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet 2 : 349-353
7. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332 : 85-87
8. Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, et al (1996) A common molecular basis for three inherited kidney stone diseases. Nature 379 : 445-449
9. Nakamura Y, Larsson C, Julier C, Bystrom C, Skogseid B, Wells S, Oberg K, et al (1989) Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11. Am J Hum Genet 44 : 751-755
10. Pang J, Lloyd S, Wooding C, Farren B, Pottinger B, Harding B, Leigh S, et al (1996) Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13, and exclusion of μ-calpain as the multiple endocrine neoplasia type 1 gene. Hum Genet 97 : 732-741
11. Pearce SHS, Trump D, Wooding C, Besser GM, Chew SL, Grant DB, Heath DA, et al (1995) Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyper-parathyroidism. J Clin Invest 96 : 2683-2692
12. Taggart RT, Qian C, Mullins C, Slusher R, An Y, Richard CW (1996) Multiple endocrine neoplasia type 1: identification of polymorphic markers and candidate genes. Am J Hum Genet 59 : A83
13. Thakker RV, Ponder BA (1988) Multiple endocrine neoplasia. Baillieres Clin Endocrinol Metab 2 : 1031-1067
14. Thakker RV, Bouloux P, Wooding D, Chotai K, Broad PM, Spurr NK, Besser GM, et al (1989) Association of parathyroid tumours in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 321 : 218-224
15. Thakker RV, Wooding C, Pang JT, Farren B, Harding B, Anderson DC, Besser GM, et al (1993) Linkage analysis of 7 polymorphic markers at chromosome 11p11.2-11q13 in 27 multiple endocrine neoplasia type 1 families. Ann Hum Genet 57 : 17-25
16. Toda T, Iida A, Miwa T, Nakamura Y, Imai T (1994) Isolation and characterization of a novel gene encoding nuclear protein at a locus (D11S636) tightly linked to multiple endocrine neoplasia type 1 (MEN1). Hum Mol Genet 3 : 465-470
17. Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, Edwards CR, et al (1996 a) Clinical studies of multiple endocrine neoplasia type I (MENI). QJM 89 : 653-669
18. Trump D, Pilia G, Dixon PH, Wooding C, Thakrar R, Leigh SE, Nagaraja R, et al (1996b) Construction of a YAC contig and an STS map spanning 3.6 megabase pairs in Xp22.1. Hum Genet 97 : 60-68
19. Weber G, Friedman E, Grimmond S, Hayward NK, Phelan C, Skogseid B, Gobi A, et al (1994) The phospholipase C beta 3 gene located in the MEN1 region shows loss of expression in endocrine tumours. Hum Mol Genet 3 : 1775-1781
20. Weber G, Grimmonds S, Lagercrautz J, Friedman E, Phelan C, Carson E, Hayward N, et al (1996) Exclusion of the phosphoinositide-specific phospholipase Cβ3 (PLCβ3) gene as a candidate for multiple endocrine neoplasia type I (MENI). Hum Genet (in press)
21. Wermer P (1954) Genetic aspects of adenomatosis of endocrine glands. Am J Med 16 : 363-367
22. Wisdom R, Yen Y, Rashid D, Verma IM (1992) Transformation by FosB requires a trans-activation domain missing in FosB2 that can be substituted by heterologous activation domains. Genes Dev 6 : 667-675
23. Xiao H, Lis JT, Xiao H, Greenblatt J, Friesen JD (1994) The upstream activator CTF/NF1 and RNA polymerase II share a common element involved in transcriptional activation. Nucleic Acids Res 22 : 1966-1973